8-K: Tilray Brands Achieves Record Q3 Revenue, Boosted by Cannabis & BrewDog Deal

Tilray Brands reported record third-quarter fiscal 2026 net revenue of $206.7 million and gross profit of $55.0 million, driven by strong international cannabis growth and strategic beverage acquisitions.

Summary

• Net revenue increased 11% to a record $206.7 million in Q3 Fiscal 2026, compared to $185.8 million in the prior year.
• Gross profit increased 6% to a record $55.0 million in Q3 Fiscal 2026, up from $52.0 million.
• Net loss improved 97% to $25.2 million, significantly down from a net loss of $793.5 million in the prior year.
• Adjusted EBITDA increased 19% to $10.7 million in Q3 Fiscal 2026, compared to $9.0 million.
• International cannabis net revenue accelerated with 73% growth year-over-year, and cannabis flower sales volume increased 100%.
• Canadian adult-use and medical cannabis net revenue combined increased 8% year-over-year, maintaining Tilray's #1 cannabis leadership position in Canada by revenue.
• The acquisition of BrewDog for approximately $40 million cash positions Tilray as a global craft beverage leader with multi-region expansion.
• The company maintains a strong balance sheet with $265 million in cash and marketable securities and a net cash position of approximately $3.5 million.
• Project 420 synergy program was completed, delivering approximately $33 million in annualized cost savings for the Beverage business.
• Fiscal Year 2026 guidance for adjusted EBITDA of $62 million to $72 million (13% to 31% growth) was reconfirmed.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, highlighted by record revenues and gross profit, a significant reduction in net loss, and strategic acquisitions that bolster future growth prospects. The reconfirmed guidance and strong balance sheet further reinforce a positive outlook, despite some segment-specific margin pressures.

Positives

• Record net revenue of $206.7 million, an 11% increase year-over-year.
• Record gross profit of $55.0 million, a 6% increase year-over-year.
• Net loss improved by 97% to $25.2 million from $793.5 million in the prior year.
• Adjusted net income improved to $2.4 million from an adjusted net loss of $2.9 million.
• Adjusted EBITDA increased 19% to $10.7 million.
• International cannabis net revenue grew 73% year-over-year, marking its best quarterly net revenue in company history.
• Cannabis flower sales volume increased 100% year-over-year.
• Canadian adult-use and medical cannabis net revenue combined increased 8%, maintaining market leadership.
• Distribution net revenue grew to a record $83.0 million.
• Wellness net revenue increased 16% to $16.4 million.
• Strong balance sheet with $264.8 million in cash, restricted cash, and marketable securities.
• Achieved a net cash position of $3.5 million, an improvement of $40.2 million from a net debt position.
• Completed Project 420, realizing $33 million in annualized cost savings for the Beverage business.
• Acquisition of BrewDog expands global craft beverage platform and distribution capabilities across multiple regions.

Negatives

• Gross margin decreased to 27% from 28% in the prior year quarter.
• Beverage net revenue decreased to $42.6 million from $55.9 million.
• Beverage gross profit decreased to $13.6 million from $19.9 million.
• Beverage gross margin decreased to 32% from 36%.
• Cannabis gross margin slightly decreased to 40% from 41%.

Risks

• Escalation of hostilities in the Middle East, including Iran, may directly and indirectly impact operating expenses and adjusted EBITDA expectations, including energy, fuel, logistics, and supply chain disruption.
• Many factors could cause actual results, performance, or achievement to be materially different from forward-looking statements.
• Risks and uncertainties not presently known or deemed immaterial could cause actual results or events to differ materially from those expressed in forward-looking statements.

Future Outlook

Tilray Brands reconfirms its fiscal year 2026 guidance for adjusted EBITDA to be between $62 million and $72 million, representing 13% to 31% growth compared to fiscal year 2025. The company is monitoring potential impacts on operating expenses and adjusted EBITDA from escalating hostilities in the Middle East, specifically concerning energy, fuel, logistics, and supply chain disruption. Strategic initiatives like the BrewDog acquisition and the Carlsberg partnership starting in 2027 are expected to accelerate the buildout of a scaled global beverage platform and drive sustained growth and profitability.

Management Comments

• "Our third quarter results demonstrated the strength of our global strategy in action, delivering our strongest Q3 net revenue and gross profit to date."
• "Our international cannabis business delivered its best quarterly net revenue in Company history, with over 70% year-over-year growth, which reflects the disciplined execution of our strategy across key global markets."
• "With the acquisition of BrewDog, the UK’s leading craft beer brand, and our recently announced partnership with Carlsberg beginning in 2027, we are accelerating the buildout of a scaled global beverage platform."
• "Supported by our diversified platform across cannabis, beverage, pharmaceutical distribution, and wellness, we are well-equipped to navigate industry headwinds while leveraging emerging opportunities driven by global consumer trends and regulatory changes."
• "We remain focused on building a leading global consumer platform designed to drive sustained growth, expand profitability, and deliver long-term shareholder value."

Industry Context

StockSavvy.ai notes that Tilray Brands' strong performance in international cannabis and strategic expansion in the craft beverage sector through the BrewDog acquisition and Carlsberg partnership positions it well within evolving global markets. The cannabis industry continues to see regulatory shifts and market expansion, particularly internationally, which Tilray is actively capitalizing on. The diversification into beverages provides a hedge against cannabis market volatility and leverages existing distribution networks, aligning with a broader trend of consumer packaged goods companies seeking diversified revenue streams.

Comparison to Industry Standards

• NA

Legal Proceedings

• Litigation costs, net of recoveries, were $621 thousand for the three months ended February 28, 2026, and $2.758 million for the same period in the prior year.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value due to record financial performance, strategic acquisitions, and reconfirmed positive guidance.
• Employees: Continued growth and expansion, particularly with the BrewDog acquisition, may lead to job stability or creation in new regions.
• Customers: Expanded product offerings and distribution channels, especially in craft beverages and international cannabis, could lead to greater product availability and choice.
• Creditors: Improved net cash position and reduction in total outstanding debt by $4.2 million indicate stronger financial health and ability to meet obligations.

Next Steps

• Integration and expansion of the BrewDog acquisition across Europe, Middle East, Australia, Asia-Pacific, and the U.S.
• Execution of the partnership with Carlsberg, commencing in 2027, to build out a global beverage platform.
• Continued monitoring of global factors, particularly Middle East hostilities, for potential impacts on operating expenses and adjusted EBITDA.
• Focus on driving sustained growth, expanding profitability, and delivering long-term shareholder value through its diversified platform.

Key Dates

Recommendation

The filing presents a compelling case for a 'buy' recommendation. Tilray Brands delivered record net revenue and gross profit, significantly reduced its net loss, and achieved positive adjusted net income. The strong growth in international cannabis, coupled with strategic acquisitions like BrewDog and the Carlsberg partnership, demonstrates a clear path for diversified global expansion and future profitability. The reconfirmed fiscal year 2026 adjusted EBITDA guidance and a robust balance sheet further underpin confidence in the company's trajectory, making it an attractive investment for long-term growth.

Keywords

Tilray Brands, TLRY, Cannabis, Beverage, Craft Beer, BrewDog, SEC Filing, 8-K, Financial Results, Q3 2026, Earnings, Revenue Growth, Adjusted EBITDA, International Cannabis, Canadian Cannabis, Wellness, Distribution, Acquisition, Carlsberg Partnership